Andrea Alcaraz

ORCID: 0000-0002-4260-8239
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Health Systems, Economic Evaluations, Quality of Life
  • Global Public Health Policies and Epidemiology
  • Obesity, Physical Activity, Diet
  • Pharmaceutical Economics and Policy
  • Health and Lifestyle Studies
  • Mosquito-borne diseases and control
  • Smoking Behavior and Cessation
  • Heart Failure Treatment and Management
  • Economic and Financial Impacts of Cancer
  • Cardiac pacing and defibrillation studies
  • Malaria Research and Control
  • Hepatitis C virus research
  • Biotechnology and Related Fields
  • Nutritional Studies and Diet
  • Chronic Disease Management Strategies
  • Lung Cancer Diagnosis and Treatment
  • Health disparities and outcomes
  • Diabetes Management and Education
  • Vaccine Coverage and Hesitancy
  • Venous Thromboembolism Diagnosis and Management
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Public Health in Brazil
  • Dengue and Mosquito Control Research
  • Hepatitis Viruses Studies and Epidemiology
  • Lung Cancer Treatments and Mutations

Instituto de Efectividad Clínica y Sanitaria
2016-2025

Hospital Universitario del Henares
2025

Universidad Privada Boliviana
2024

Consejo Nacional de Investigaciones Científicas y Técnicas
2016-2022

Cardiovascular disease (CVD) is the primary cause of mortality and morbidity in Argentina representing 34.2% deaths 12.6% potential years life lost (PYLL). The aim study was to estimate burden acute coronary heart (CHD) stroke cost-effectiveness preventative population-based clinical interventions. An epidemiological model built incorporating prevalence distribution high blood pressure, cholesterol, hyperglycemia, overweight obesity, smoking, physical inactivity, obtained from Argentine...

10.1186/1471-2458-10-627 article EN cc-by BMC Public Health 2010-10-20

BackgroundWorldwide, smoking tobacco causes 7 million deaths annually, and this toll is expected to increase, especially in low-income middle-income countries. In Latin America, a leading risk factor for death disability, contributes poverty, imposes an economic burden on health systems. Despite being one of the most effective measures reduce smoking, taxation underused cigarettes are more affordable America than other regions. Our aim was estimate tobacco-attributable mortality, disease...

10.1016/s2214-109x(20)30311-9 article EN cc-by The Lancet Global Health 2020-09-21

To investigate the tobacco-attributable burden on disease, medical costs, productivity losses and informal caregiving; to estimate health economic gains that can be achieved if main tobacco control measures (raising taxes tobacco, plain packaging, advertising bans smoke-free environments) are fully implemented in eight countries encompass 80% of Latin American population.

10.1136/tc-2022-057618 article EN cc-by-nc Tobacco Control 2023-05-04

Background Lung cancer (LC) is a leading cause of mortality in Argentina. Low-dose computed tomography (LDCT) had demonstrated higher efficacy than chest radiography as screening method for early detection and reducing LC mortality. This study estimates the Budget Impact implementing annual LDCT individuals aged 55-74 with at least 30 pack-years smoking

10.1080/14737167.2025.2460523 article EN Expert Review of Pharmacoeconomics & Outcomes Research 2025-01-28
María D. Ballesteros‐Pomar Jj AlfaroMartínez Juan Manuel Guardia-Baena María Riestra Fernández Belén Vega‐Piñero and 95 more Ana Artero Fullana Montserrat Gonzalo Marín Daniel Antonio de Luis Ana Jiménez Portilla Juan Camilo Ochoa M. Ventosa Viña Silvia Veses Martín Araceli Muñoz‐Garach M. Fernández Christian Salom Vendrell Juan Manuel Guardia Baena Pablo Carbo María José Hernández María Berrio Miranda María Victoria Hernández Jiménez Nian Xiong Victoria Luna López Carlos E. Muñiz Mercedes García María José Jiménez Jiménez Felipe Alvarez Navia Katherine García Malpartida F. Baró Guilherme Carvalho Monterio Pablo Flors Villaverde Mercedes Vázquez Gutiérrez Ángel Pedro Crisolino Pozas Mara Alarcón Chulilla R Pérez Arturo Lisbona Catalán Andrea Micó García V Barriales Alvarez Laura Mola Reyes Rafael Castillo Rubio Eduardo Platero Rodrigo Beatriz Ugalde Abiega Salvador Benlloch Silvia Pérez Marco Villa Ángel Luis Abad-González Miguel Antonio Sampedro Núñez A. Bayona Cebada Nataly Gardenia Ortega Romero Sara Jiménez Blanco Patricia Díaz Guardiola Teresa García Eduardo Milton Ramos-Sanchez Rocío Campos del Portillo Carmen Ballesta Sánchez Cristina Aguilera Elena Carrillo Lozano Joaquín Escribano Maria Angeles Valero Zany Juan Jacobo Molina María José Pena López María Maíz Jiménez Irene Gonzalo Montesinos Elena Abad Sergio Fuentes Tudanca Diana Ariadel Cobo A. I. Zomeño Ros Olga Sánchez-Vilar Laura De La Maza Virginia Esperanza Fernandez Ruiz Marta Llorca Estefanía Santos Mazo Sandra Fernandes Lucas Clara Marcuello Ana Urioste Fondo Andrea Alcaraz María Alonso Casasús Marco Antonio Peña Duque A. Cremades Pablo José Ferreira Ocampo Elena González Arnáiz Mercedes Ferrer Gómez D. Martín Iglesias Soraya Lanes Iglesias Arantzazu Barquín César Gonzalvo Díaz Ana Hernández Moreno Rosa Ruiz Lopez Lourdes García Blasco Maria Jesús Chinchetru Antonio Jesús Martínez-Ortega Antonio José Blanco Orenes Octavio Pérez Alonso Beatriz González Aguilera José Antonio Martínez Alfredo Molina Irene Navarro Rosa de Diego Martínez Carmen Ripa Ciaurriz Juana María Rabat Restrepo Francisco Javier Gómez Alfonso

10.1016/j.nutos.2025.02.007 article EN cc-by Clinical Nutrition Open Science 2025-02-01

Objetivos. Sintetizar la evidencia sobre el impacto de implementación prohibición publicidad, promoción y patrocinio (PPP) bebidas azucaradas (BA) en términos disminución consumo, exposición publicitaria desenlaces clínicos relevantes. Materiales métodos. Revisión sistemática estudios publicados entre 2001-2021 las bases datos PubMed, Embase, Global Health, CINAHL LILACS escritos inglés, portugués o español. Se incluyeronestudios experimentales, observacionales modelos económicos. evaluó...

10.17843/rpmesp.2025.421.14023 article ES cc-by-nc Revista Peruana de Medicina Experimental y Salud Pública 2025-02-17

The prevalence of smoking in Brazil has decreased considerably recent decades, but the country still a high burden disease associated with this risk factor. study aimed to estimate mortality, morbidity, and costs for society 2015 potential impact on health outcomes economy based price increases cigarettes through taxes. Two models were developed: first is mathematical model probabilistic microsimulation thousands individuals using hypothetical cohorts that considered natural history, costs,...

10.1590/0102-311x00129118 article ES cc-by Cadernos de Saúde Pública 2019-01-01

Background Decision-makers have begun to recognize Health-Related Quality of Life (HRQoL) as an important and measurable outcome healthcare interventions; HRQoL data is increasingly being used by policy-makers prioritize health resources. Our objective was measure in a group Type 2 Diabetes Mellitus (T2DM) patients receiving insulin treatment Buenos Aires, Argentina. Methods We conducted cross-sectional study with T2DM over 21 years age, treated either Neutral Protamine Hagedorn (NPH) or...

10.15171/ijhpm.2015.80 article EN cc-by International Journal of Health Policy and Management 2015-04-10

Lung cancer remains a significant global public health challenge and is still one of the leading causes cancer-related death in Argentina. This study aims to assess disease economic burden lung country.

10.1016/j.puhe.2024.03.027 article EN cc-by Public Health 2024-05-16

OBJETIVO: Estimar la carga de enfermedad, su proporción atribuible a los principales factores riesgo cardiovascular modificables y costos médicos directos por hospitalización, asociados con las enfermedades coronarias accidentes cerebrovasculares en Argentina. MÉTODOS: Se elaboró un modelo analítico partir datos mortalidad Argentina 2005 prevalencia (hipertensión arterial, hipercolesterolemia, sobrepeso, obesidad, hiperglucemia, tabaquismo actual pasado, sedentarismo consumo inadecuado...

10.1590/s1020-49892010000400001 article ES Revista Panamericana de Salud Pública 2010-04-01

Abstract Tobacco tax increases, the most cost‐effective measure in reducing consumption, remain underutilized low and middle‐income countries. This study estimates health economic burden of smoking Argentina forecasts benefits tobacco hikes, accounting for potential effects illicit trade. Using a probabilistic Markov microsimulation model, this quantifies smoking‐related deaths, events, societal costs. The model also different increases price cigarettes through taxes. Annually, causes 45,000...

10.1002/hec.4741 article EN cc-by Health Economics 2023-07-31
Coming Soon ...